China Universal Asset Management Company’s Structure Therapeutics GPCR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $248K | Buy |
11,967
+16
| +0.1% | +$332 | 0.02% | 293 |
|
|
2025
Q1 | $207K | Sell |
11,951
-683
| -5% | -$11.8K | 0.02% | 311 |
|
|
2024
Q4 | $343K | Buy |
12,634
+1,174
| +10% | +$31.8K | 0.03% | 284 |
|
|
2024
Q3 | $503K | Buy |
11,460
+5,707
| +99% | +$250K | 0.06% | 217 |
|
|
2024
Q2 | $226K | Sell |
5,753
-3,623
| -39% | -$142K | 0.03% | 224 |
|
|
2024
Q1 | $402K | Buy |
9,376
+5,027
| +116% | +$215K | 0.05% | 204 |
|
|
2023
Q4 | $177K | Buy |
4,349
+2,939
| +208% | +$120K | 0.03% | 216 |
|
|
2023
Q3 | $71.1K | Sell |
1,410
-25,857
| -95% | -$1.3M | 0.02% | 218 |
|
|
2023
Q2 | $1.13M | Buy |
+27,267
| New | +$1.13M | 0.35% | 73 |
|